Investment
Features
FeesSafety
Academy
More
Pluang+

KB Home Q3 earnings expected to drop sharply, with revenue and EPS forecast down significantly.

Company Fundamentals
17 Sep 2026
Andrew Wynn
View Source
Bearish
KB Home Q3 earnings expected to drop sharply, with revenue and EPS forecast down significantly.

KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has recently been revised downward by 2.2%, signaling increased caution among analysts. Despite these challenges, KB Home maintains strong financial health, with a low debt-to-equity ratio of 0.53 and a high current ratio of 6.80, indicating solid liquidity and manageable debt levels. Investors will watch the report closely for signs of how the homebuilder is navigating a tough market environment.

KB Home's Q3 2026 earnings preview notes a projected 45.3% decline in EPS and a 20.2% drop in revenue compared to last year. For readers following the Consumer Cyclical sector, here is Pluang's market snapshot as of Sep 18, 2026 01:51 WIB: out of 105 priced US stocks, 67 rose and 36 fell. Notable movers include RENT at USD 1.88 with 8% Sell / 92% Buy order activity, GAP at USD 20.83 up 3.27%, and BBY at USD 94.47 up 3.26% with 0% Sell / 100% Buy order activity and a typical hold time of 64 days on Pluang.

More News

Jefferies keeps Kinder Morgan on Hold, lowers price target to $33 amid stable cash flows and growth.

Jefferies keeps Kinder Morgan on Hold, lowers price target to $33 amid stable cash flows and growth.

Jefferies maintained a Hold rating on Kinder Morgan, lowering its price target from $35 to $33, which remains above the current stock price of $31.31. The company benefits from stable cash flows, with 96% secured by fee-based or hedged contracts, inc...

Analyst Insights
Neutral
17 minutes ago
Stocks surge on patent wins, financing deals, and merger announcements.

Stocks surge on patent wins, financing deals, and merger announcements.

Several stocks saw sharp gains driven by key company developments. bioAffinity Technologies surged 63.55% after securing a Hong Kong patent for its lung cancer diagnostic technology, boosting its Asian market position. Antelope Enterprise Holdings ro...

Market News
Bullish
25 minutes ago
$10,000 invested in Nebius in 2024 is now worth about $105,000 in 2026

$10,000 invested in Nebius in 2024 is now worth about $105,000 in 2026

An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...

Market News
Bullish
2 hours ago
W.P. Carey projects $1.9B investment in 2026 with strong tenant outlook and institutional support.

W.P. Carey projects $1.9B investment in 2026 with strong tenant outlook and institutional support.

W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...

Analyst Insights
Bullish
3 hours ago
Micron invests $10B in new research labs, backed by strong financial health and strategic leadership.

Micron invests $10B in new research labs, backed by strong financial health and strategic leadership.

Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App